J Korean Soc Biol Psychiatry.  2000 Jul;7(1):34-45.

Drug-Drug Interactions: Mood Stabilizers and Anti-Anxiety Drugs

Abstract

Pharmacotherapy of bipolar disorder is a rapidly evolving field. Mood stabilizers and anticonvulsants have varying biochemical profiles which may predispose them to different adverse effects and drug-drug interactions. Several of the new anticonvulsants appear less likely to have the problems with drug-drug interaction. To provide more effective combination pharmacotherapies, clinicians should be allowed to anticipate and avoid pharmacokinetic and pharmacodynamic drug-drug interactions. We reviewed the role of cytochrome P450 isozymes in the metabolism of the drugs and their interactions. The drug-drug interactions of several classes of drugs which used as mood stabilizers and new anticonvulsants, some of which may have psychotropic profiles, are discussed mainly in this article. Finally, potential pharmacokinetic interactions between the benzodiazepines and other coadministered drugs are discussed briefly.


MeSH Terms

Anti-Anxiety Agents*
Anticonvulsants
Benzodiazepines
Bipolar Disorder
Cytochrome P-450 Enzyme System
Drug Therapy
Isoenzymes
Metabolism
Anti-Anxiety Agents
Anticonvulsants
Benzodiazepines
Cytochrome P-450 Enzyme System
Isoenzymes
Full Text Links
  • JKJBP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr